Literature DB >> 35514098

Scleredema developing after SARS-CoV-2 infection: a possible novel skin manifestation of coronavirus disease.

Manuel Sánchez-Díaz1, Ruben Lobato-Cano2, Luis Salvador-Rodríguez1, David Lopez-Delgado1, Beatriz Espadafor-Lopez1, Francisco Vilchez-Marquez1, Francisco Ramos-Pleguezuelos3, Alejandro Molina-Leyva1, Salvador Arias-Santiago4.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35514098      PMCID: PMC9170550          DOI: 10.1684/ejd.2021.4191

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   2.805


× No keyword cloud information.
  9 in total

1.  Scleredema of Buschke Following Streptococcal Infection.

Authors:  Soo-Eun Jung; You Chan Kim
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

2.  Scleredema diabeticorum: Description of 11 cases.

Authors:  Olga Simó-Guerrero; Assumpta Recasens-Gracia; Gabriel Giménez-Pérez
Journal:  Med Clin (Barc)       Date:  2019-02-01       Impact factor: 1.725

Review 3.  Treatment of Scleroedema Adultorum Buschke: A Systematic Review.

Authors:  Diana Miguel; Sibylle Schliemann; Peter Elsner
Journal:  Acta Derm Venereol       Date:  2018-03-13       Impact factor: 4.437

4.  European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.

Authors:  R Knobler; P Moinzadeh; N Hunzelmann; A Kreuter; A Cozzio; L Mouthon; M Cutolo; F Rongioletti; C P Denton; L Rudnicka; L A Frasin; V Smith; A Gabrielli; E Aberer; M Bagot; G Bali; J Bouaziz; A Braae Olesen; I Foeldvari; C Frances; A Jalili; U Just; V Kähäri; S Kárpáti; K Kofoed; D Krasowska; M Olszewska; C Orteu; J Panelius; A Parodi; A Petit; P Quaglino; A Ranki; J M Sanchez Schmidt; J Seneschal; A Skrok; M Sticherling; C Sunderkötter; A Taieb; A Tanew; P Wolf; M Worm; N J Wutte; T Krieg
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-08-08       Impact factor: 6.166

Review 5.  Scleroderma mimics.

Authors:  Jennifer Nashel; Virginia Steen
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

6.  Idiopathic scleredema.

Authors:  Elise Ng; Rachel Rosenstein; Vitaly Terushkin; Shane Meehan; Miriam Keltz Pomeranz
Journal:  Dermatol Online J       Date:  2016-12-15

Review 7.  Cutaneous mucinoses and HIV infection.

Authors:  F Rongioletti; G Ghigliotti; R De Marchi; A Rebora
Journal:  Br J Dermatol       Date:  1998-12       Impact factor: 9.302

8.  Case Report: Systemic Sclerosis After Covid-19 Infection.

Authors:  Serena Fineschi
Journal:  Front Immunol       Date:  2021-06-28       Impact factor: 7.561

9.  Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.

Authors:  Farnoosh Seirafianpour; Sogand Sodagar; Arash Pour Mohammad; Parsa Panahi; Samaneh Mozafarpoor; Simin Almasi; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-08-06       Impact factor: 3.858

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.